» Articles » PMID: 29172684

Faster and Safer? FLASH Ultra-high Dose Rate in Radiotherapy

Overview
Journal Br J Radiol
Specialty Radiology
Date 2017 Nov 28
PMID 29172684
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Recent results from the Franco-Swiss team of Institute Curie and Centre Hospitalier Universitaire Vaudois demonstrate a remarkable sparing of normal tissue after irradiation at ultra-high dose rate (>40 Gy s). The "FLASH" radiotherapy maintains tumour control level, suggesting that ultra-high dose rate can substantially enhance the therapeutic window in radiotherapy. The results have been obtained so far only with 4-6 MeV electrons in lung and brain mouse model. Nevertheless, they have attracted a great attention for the potential clinical applications. Oxygen depletion had been discussed many years ago as a possible mechanism for reduction of the damage after exposure to ultra-high dose rate. However, the mechanism underlying the effect observed in the FLASH radiotherapy remains to be elucidated.

Citing Articles

FLASH radiotherapy: mechanisms, nanotherapeutic strategy and future development.

Wang Y, Wang H, Hu J, Chai J, Luan J, Li J Nanoscale Adv. 2025; 7(3):711-721.

PMID: 39781242 PMC: 11705069. DOI: 10.1039/d4na00753k.


Microstrip plastic scintillating detector system for quality assurance in synchrotron microbeam radiotherapy.

Thevenet F, Keshmiri S, Degouttes J, Livingstone J, Lu G, Adam J Sci Rep. 2025; 15(1):277.

PMID: 39747355 PMC: 11696310. DOI: 10.1038/s41598-024-80736-0.


FLASH Radiotherapy: Benefits, Mechanisms, and Obstacles to Its Clinical Application.

Alhaddad L, Osipov A, Leonov S Int J Mol Sci. 2024; 25(23).

PMID: 39684218 PMC: 11641130. DOI: 10.3390/ijms252312506.


Mimicking large spot-scanning radiation fields for proton FLASH preclinical studies with a robotic motion platform.

Guan F, Jiang D, Wang X, Yang M, Iga K, Li Y ArXiv. 2024; .

PMID: 39314510 PMC: 11419177.


Organization and operation of multi particle therapy facilities: the Marburg Ion-Beam Therapy Center, Germany (MIT).

Zink K, Baumann K, Theiss U, Subtil F, Lahrmann S, Eberle F Health Technol (Berl). 2024; 14(5):929-938.

PMID: 39219555 PMC: 11358185. DOI: 10.1007/s12553-024-00881-4.


References
1.
Fernet M, Ponette V, Deniaud-Alexandre E, de Murcia G, Giocanti N, Megnin-Chanet F . Poly(ADP-ribose) polymerase, a major determinant of early cell response to ionizing radiation. Int J Radiat Biol. 2001; 76(12):1621-9. DOI: 10.1080/09553000050201118. View

2.
Yovino S, Kleinberg L, Grossman S, Narayanan M, Ford E . The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest. 2013; 31(2):140-4. PMC: 3991115. DOI: 10.3109/07357907.2012.762780. View

3.
Wilson P, Jones B, Yokoi T, Hill M, Vojnovic B . Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ions. Br J Radiol. 2012; 85(1018):e933-9. PMC: 3474025. DOI: 10.1259/bjr/17827549. View

4.
Town C . Radiobiology. Effect of high dose rates on survival of mammalian cells. Nature. 1967; 215(5103):847-8. DOI: 10.1038/215847a0. View

5.
Cornforth M, Bailey S, Goodwin E . Dose responses for chromosome aberrations produced in noncycling primary human fibroblasts by alpha particles, and by gamma rays delivered at sublimiting low dose rates. Radiat Res. 2002; 158(1):43-53. DOI: 10.1667/0033-7587(2002)158[0043:drfcap]2.0.co;2. View